GHISLAINE MAXWELL- OAP FDG ACCT. For the Period 1/1112 to 1/31/12 Equity Summary Asset Categories US Large Cap Equity 160.064.44 156,814.37 (3,250.07) 9585 Concentrated .3 Other Equity 0.00 5,051.04 5,051.04 3% Total Value $160,064.44 $161,865.41 $1,800.97 98% Beginning Ending Change Current Asset Categories Market Value Market Value In Value Allocation Market Value/Cost Current Period Value Market Value 161.865.41 Tax Cost 146.974.44 Unrealized Gain;Loss 14990.97 Estimated Annual Income 5,407.27 Accrued Dividends 405.99 Yield 3.34% Note- P indicates position adjusted for Pending Trade Activity. Equity Detail COMOIlf arid 6 Other Eqfitif *US Lap Cep EcitNty Equity as a percentage of your portfolio - 98 % Adjusted Tax Cost Unrealized Est Annual Inc Price Quantity Value Original Cost Gain.toss Accrued Div. Yield US Large Cap Equity ABBOTT LABORATORIES 002824-10-0 AST 54.15 148.000 8,014.20 7,308.74 705.48 284.16 71.04 3.55% ANALOG DEVICES INC 39.13 176.000 6,886.88 8,011.39 875.49 176.00 2.56% 032854-10-5 ADI JP Morgan Page 4 of 11 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00049623 SDNY_GM_00318821 EFTA01522138